No, GLP-1 receptor agonists are not licensed by the MHRA specifically for treating inflammatory conditions
Retatrutide is grouped for metabolic and incretin-pathway research-material sourcing, so the useful procurement review includes incretin, amylin, metabolic-pathway, SKU ladder, and batch-file readiness in addition to identity fields, SKU size, MOQ, and quote terms
PlexusDx's Precision Peptide Genetic Test ($99 after month one) analyzes 14 metabolic pathways and 49 peptides, identifying variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313
Baseline estimated renal function was normal (eGFR 90 mL/min/1.73 m2) in 66.2%, mildly impaired (eGFR 60 to 90 mL/min/1.73 m2) in 32.4% and moderately impaired (eGFR 30 to 60 mL/min/1.73 m2) in 1.4% of patients
For patients seeking maximum impact, PlexusDx GLP-Squared Injection combines both compounds in one formulation, at $289/mo month-to-month, or from $249/mo on the 6-month plan
